N- (Mal-PEG4) -N- (PEG4-Val-Cit-PAB-MMAF) -N- (PEG4-Val-Cit-PAB-Exatecan)
N- (Mal-PEG4) -N- (PEG4-Val-Cit-PAB-MMAF) -N- (PEG4-Val-Cit-PAB-Exatecan) is a drug-linker conjugate for ADC (Drug-Linker Conjugate for ADC), consisting of a tubulin polymerization inhibitor MMAE and a DNA topoisomerase I inhibitor Exatecan (HY-13631), and an ADC linker composition. N- (Mal-PEG4) -N- (PEG4-Val-Cit-PAB-MMAF) -N- (PEG4-Val-Cit-PAB-Exatecan) can be used for synthesis of ADCs and for cancer research.
Product Specifications
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Microtubule/Tubulin; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Field of Research
Cancer
Smiles
O=C(N[C@@H](C(C)C)C(N[C@H](C(NC1=CC=C(COC(N(C)[C@H](C(N[C@@H](C(C)C)C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N2[C@H]([C@H](OC)[C@@H](C)C(N[C@@H](CC3=CC=CC=C3)C(O)=O)=O)CCC2)=O)C)=O)=O)C(C)C)=O)C=C1)=O)CCCNC(N)=O)=O)CCOCCOCCOCCOCCC(N(CCOCCOCCOCCOCCN4C(C=CC4=O)=O)CCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=O)C(NC(C=C5)=CC=C5COC(N[C@H]6CCC7=C8C6=C9C(C(N%10C9)=CC([C@](CC)(O)C(OC%11)=O)=C%11C%10=O)=NC8=CC(F)=C7C)=O)=O)=O)=O)=O
Molecular Formula
C138H201FN20O39
Molecular Weight
2783.18
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400040-100 1x 100 µL
CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040460-500 1x 500 µL
CD44 Standard (156-3C11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details